PROVIDER PROFILE · NPI 1205178134
Fahad ZubairMD
PRESCRIBING · PART D · 2024
Total Rx claims
748
Beneficiaries
—
Total drug cost
$422K
Distinct drugs
10
Brand share
57.5%
Top prescribed drugs
Tirzepatide156 claims
Topiramate138 claims
Naltrexone Hcl135 claims
Semaglutide85 claims
Semaglutide50 claims
QUALITY · MIPS · 2024
Final MIPS score
93.9
Quality
85.0
Cost
0.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.80%
APM Entity
CROSS-REFERENCE